COMT hemizygosity in 22q11DS is suggested to result in reduced COMT enzyme activity and consequently higher DA levels, especially in the PFC (Tunbridge et al., 2006; Boot et al., 2008; van Beveren et al., 2012), in line with our findings. This evidence concerns the gene COMT and 22q11.2 deletion syndrome.